Answers are grounded in this paper and cite their sources.
The additional cost per patient of the CRP test is outweighed by the associated cost savings and QALY increment associated with a reduction in infections in the long term.
No takes yet. Share an insight, caveat, or question.
Rachael Hunter (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: